The chief executive of health watchdog Nice told ITV News he is "disappointed" that drug manufacturer Roche has not offered the NHS a discount on a breast cancer drug that costs around £90,000 per patient.
Kadcyla, which extends women's lives by almost six months, could be blocked from routine NHS access because it is too expensive.
"Companies can discount their prices and they frequently do. Given the list price. I would have expected the company to have at least considered (a discount)," Andrew Dillon said.
More top news
Nick Boles warned the PM it was "time to raise your game" and claimed her government "constantly disappoints" in a tweet.
The Foreign Office warned holidaymakers that "intensive law enforcement activities" were expected in Montego Bay.
The man who sold himself to the American people as the greatest deal maker in history is now overseeing paralysis.